(Q53465310)

English

Viral, HLA and T cell elements in cross-reactive immune responses to HIV-1 subtype A, CRF01_AE and CRF02_AG vaccine sequence in Ivorian blood donors.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18640166%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

Viral, HLA and T cell elements in cross-reactive immune responses to HIV-1 subtype A, CRF01_AE and CRF02_AG vaccine sequence in Ivorian blood donors (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18640166%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18640166%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

author name string

M Aidoo

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18640166%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

S Sawadogo

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18640166%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

C Yang

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18640166%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

J N Nkengasong

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18640166%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

J M McNicholl

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18640166%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

language of work or name

0 references

publication date

18 July 2008

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18640166%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18640166%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

26

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18640166%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

37

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18640166%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

4830-4839

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18640166%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

Molecular epidemiology of HIV-1 genetic forms and its significance for vaccine development and therapy.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.06.097

7 January 2021

New HIV type 1 CRF01_AE/B recombinants displaying unique distribution of breakpoints from incident infections among injecting drug users in Thailand

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.06.097

7 January 2021

Generation of a consensus sequence from prevalent and incident HIV-1 infections in West Africa to guide AIDS vaccine development

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.06.097

7 January 2021

Human immunodeficiency virus type 1 subtype C Gag virus-like particle boost substantially improves the immune response to a subtype C gag DNA vaccine in mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.06.097

7 January 2021

Safety and immunogenicity of combinations of recombinant subtype E and B human immunodeficiency virus type 1 envelope glycoprotein 120 vaccines in healthy Thai adults.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.06.097

7 January 2021

MHC heterozygosity confers a selective advantage against multiple-strain infections

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.06.097

7 January 2021

HLA supertypes and supermotifs: a functional perspective on HLA polymorphism

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.06.097

7 January 2021

T cell immunodominance and maintenance of memory regulated by unexpectedly cross-reactive pathogens

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.06.097

7 January 2021

The flexibility of the TCR allows recognition of a large set of naturally occurring epitope variants by HIV-specific cytotoxic T lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.06.097

7 January 2021

Selective expansion of cross-reactive CD8(+) memory T cells by viral variants.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.06.097

7 January 2021

HLA and HIV-1: heterozygote advantage and B*35-Cw*04 disadvantage

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.06.097

7 January 2021

Eventual AIDS vaccine failure in a rhesus monkey by viral escape from cytotoxic T lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.06.097

7 January 2021

T cell receptor usage of virus-specific CD8 cells and recognition of viral mutations during acute and persistent hepatitis B virus infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.06.097

7 January 2021

A balanced type 1/type 2 response is associated with long-term nonprogressive human immunodeficiency virus type 1 infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.06.097

7 January 2021

HIV-specific CD8+ T cell proliferation is coupled to perforin expression and is maintained in nonprogressors

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.06.097

7 January 2021

HIV-specific cellular immune response is inversely correlated with disease progression as defined by decline of CD4+ T cells in relation to HIV RNA load

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.06.097

7 January 2021

Loss of CD4+ T cell proliferative ability but not loss of human immunodeficiency virus type 1 specificity equates with progression to disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.06.097

7 January 2021

Identification of Sequential Viral Escape Mutants Associated with Altered T-Cell Responses in a Human Immunodeficiency Virus Type 1-Infected Individual

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.06.097

7 January 2021

Optimization of a multi-gene HIV-1 recombinant subtype CRF02_AG DNA vaccine for expression of multiple immunogenic forms

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.06.097

7 January 2021

Comparative immunogenicity in rhesus monkeys of multi-protein HIV-1 (CRF02_AG) DNA/MVA vaccines expressing mature and immature VLPs

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.06.097

7 January 2021

HIV-1 DNA/MVA vaccination reduces the per exposure probability of infection during repeated mucosal SHIV challenges

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.06.097

7 January 2021

Forty-one near full-length HIV-1 sequences from Kenya reveal an epidemic of subtype A and A-containing recombinants

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.06.097

7 January 2021

Evaluation of HIV serial and parallel serologic testing algorithms in Abidjan, Côte d'Ivoire

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.06.097

7 January 2021

Comprehensive epitope analysis of human immunodeficiency virus type 1 (HIV-1)-specific T-cell responses directed against the entire expressed HIV-1 genome demonstrate broadly directed responses, but no correlation to viral load.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.06.097

7 January 2021

Comprehensive screening for human immunodeficiency virus type 1 subtype-specific CD8 cytotoxic T lymphocytes and definition of degenerate epitopes restricted by HLA-A0207 and -C(W)0304 alleles

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.06.097

7 January 2021

Genetic variation of HIV type 1 in four World Health Organization-sponsored vaccine evaluation sites: generation of functional envelope (glycoprotein 160) clones representative of sequence subtypes A, B, C, and E. WHO Network for HIV Isolation and C

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.06.097

7 January 2021

Predominance of HIV type 1 subtype G among commercial sex workers from Kinshasa, Democratic Republic of Congo

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.06.097

7 January 2021

CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.06.097

7 January 2021

Measurement of HIV-1 CRF02_AG-specific T cell responses indicates the dominance of a p24gag epitope in blood donors in Abidjan, Cote d'Ivoire

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.06.097

7 January 2021

HLA-B allele frequencies in Côte d'Ivoire defined by direct DNA sequencing: identification of HLA-B*1405, B*4410, and B*5302.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.06.097

7 January 2021

Detection of high frequencies of HIV-1 cross-subtype reactive CD8 T lymphocytes in the peripheral blood of HIV-1-infected Kenyans

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.06.097

7 January 2021

Cross-reactive cytotoxic T lymphocytes against a HIV-1 p24 epitope in slow progressors with B*57.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.06.097

7 January 2021

Cross-clade T lymphocyte-mediated immunity to HIV type 1: implications for vaccine design and immunodetection assays.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.06.097

7 January 2021

Clustered mutations in HIV-1 gag are consistently required for escape from HLA-B27-restricted cytotoxic T lymphocyte responses.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.06.097

7 January 2021

Selective escape from CD8+ T-cell responses represents a major driving force of human immunodeficiency virus type 1 (HIV-1) sequence diversity and reveals constraints on HIV-1 evolution

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.06.097

7 January 2021

Consistent cytotoxic-T-lymphocyte targeting of immunodominant regions in human immunodeficiency virus across multiple ethnicities

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.06.097

7 January 2021

Involvement of multiple epitope-specific cytotoxic T-lymphocyte responses in vaccine-based control of simian immunodeficiency virus replication in rhesus macaques

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.06.097

7 January 2021

Evolution of human immunodeficiency virus type 1 cytotoxic T-lymphocyte epitopes: fitness-balanced escape

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.06.097

7 January 2021

Control of a mucosal challenge and prevention of AIDS by a multiprotein DNA/MVA vaccine.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.06.097

7 January 2021

Gp120-alum boosting of a Gag-Pol-Env DNA/MVA AIDS vaccine: poorer control of a pathogenic viral challenge

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.06.097

7 January 2021

Cross-subtype antibody and cellular immune responses induced by a polyvalent DNA prime-protein boost HIV-1 vaccine in healthy human volunteers

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.06.097

7 January 2021

Cellular immune responses induced with dose-sparing intradermal administration of HIV vaccine to HIV-uninfected volunteers in the ANRS VAC16 trial

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.06.097

7 January 2021

Phase I clinical evaluation of a six-plasmid multiclade HIV-1 DNA candidate vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.06.097

7 January 2021

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q53465310&oldid=1368949346"